This video examines current options for the treatment of midgut neuroendocrine tumors and highlights results of the NETTER-1 trial.
Jonathan Strosberg, MD
Advertisement
Articles by Jonathan Strosberg, MD
In this review, we summarize biologic, pathologic, and clinical aspects of gastroenteropancreatic-neuroendocrine tumors, focusing on recent advances in their treatment.
Advertisement
Latest Updated Articles
An Update on Gastroenteropancreatic Neuroendocrine TumorsPublished: September 15th 2014 | Updated:
Treatment of Midgut Neuroendocrine TumorsPublished: February 10th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?
2
Single-Agent PD-1 Blockade Therapy Improves Responses in Desmoplastic Melanoma
3
64Cu-SAR-bisPSMA PET Detects More Prostate Cancer Lesions vs SOC
4
Real-World Data From IMS: Promising Results in Relapsed/Refractory Multiple Myeloma
5
